UnitedHealth Group (NYSE:UNH) Given New $562.00 Price Target at Deutsche Bank Aktiengesellschaft

UnitedHealth Group (NYSE:UNH) had its price objective upped by Deutsche Bank Aktiengesellschaft from $545.00 to $562.00 in a research report released on Friday, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the healthcare conglomerate’s stock.

UNH has been the topic of a number of other reports. Cantor Fitzgerald reiterated an overweight rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Barclays lifted their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an overweight rating in a report on Wednesday. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an overweight rating on the stock in a report on Friday, April 5th. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an overweight rating on the stock in a report on Monday, April 8th. Finally, Truist Financial restated a buy rating and set a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of Moderate Buy and an average price target of $570.05.

UnitedHealth Group Stock Up 1.6 %

UnitedHealth Group stock opened at $501.29 on Friday. The company’s 50 day simple moving average is $488.63 and its 200 day simple moving average is $515.13. UnitedHealth Group has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The firm has a market capitalization of $462.15 billion, a price-to-earnings ratio of 30.64, a PEG ratio of 1.35 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the previous year, the firm posted $6.26 earnings per share. The business’s revenue was up 8.6% on a year-over-year basis. As a group, sell-side analysts anticipate that UnitedHealth Group will post 27.74 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.50%. UnitedHealth Group’s payout ratio is presently 45.97%.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On UnitedHealth Group

Several institutional investors and hedge funds have recently bought and sold shares of UNH. Robbins Farley bought a new position in shares of UnitedHealth Group in the third quarter worth about $25,000. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $26,000. CGC Financial Services LLC lifted its holdings in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. True Wealth Design LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $31,000. Finally, NewSquare Capital LLC lifted its holdings in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.